A031501 AMBASSADOR
A031501 AMBASSADOR: Phase III Trial of Pembrolizumab vs Observation as Adjuvant Therapy for High-Risk Muscle-Invasive Urothelial Carcinoma

Released: February 02, 2024

Activity

Progress
1
Course Completed